Montclair, NJ, December 2, 2013 ― It has been called the crown jewel of the New Jersey economy. Citing HINJ’s latest economic impact survey, Lauren Wanko reported on “NJTV News with Mike Schneider” that the biopharmaceutical and medical technology industries generated over $26 billion in economic impact for the Garden State in 2012.
“We call this the ‘Medicine Chest of the World,’” said HINJ President and Chief Executive Officer Dean Paranicas. “This is New Jersey’s premier industry. In fact, we have the largest concentration of companies of its type in the world.”
The HINJ economic impact study indicates a nearly 10 percent increase in economic activity from 2010.
“We’re very pleased with it because it demonstrates the resilience of our companies in terms of managing through difficult economic times and working to benefit from the improving economy,” Paranicas said.
To view the NJTV News segment, click here.